Lobato-Freitas, C.; Brito-da-Costa, A.M.; Dinis-Oliveira, R.J.; Carmo, H.; Carvalho, F.; Silva, J.P.; Dias-da-Silva, D.
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications. Pharmaceuticals 2021, 14, 186.
https://doi.org/10.3390/ph14030186
AMA Style
Lobato-Freitas C, Brito-da-Costa AM, Dinis-Oliveira RJ, Carmo H, Carvalho F, Silva JP, Dias-da-Silva D.
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications. Pharmaceuticals. 2021; 14(3):186.
https://doi.org/10.3390/ph14030186
Chicago/Turabian Style
Lobato-Freitas, Carolina, Andreia Machado Brito-da-Costa, Ricardo Jorge Dinis-Oliveira, Helena Carmo, Félix Carvalho, João Pedro Silva, and Diana Dias-da-Silva.
2021. "Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications" Pharmaceuticals 14, no. 3: 186.
https://doi.org/10.3390/ph14030186
APA Style
Lobato-Freitas, C., Brito-da-Costa, A. M., Dinis-Oliveira, R. J., Carmo, H., Carvalho, F., Silva, J. P., & Dias-da-Silva, D.
(2021). Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications. Pharmaceuticals, 14(3), 186.
https://doi.org/10.3390/ph14030186